Diabetes

BETHESDA, Md. — Good results from an investigational diabetes drug made by Spherix may result from higher body mass indexes among U.S. patients, according to results of a late-stage clinical trial announced Thursday.

Spherix said results of the phase-3 trial conducted among American and Indian patients indicated that D-tagatose may be more effective in lowering HbA1c levels due to Americans having higher BMIs on average than Indians.

BOSTON — According to a report in the December 2010 issue of the Harvard Health Letter, Americans are maintaining intimacy through their 60s, 70s and even 80s.

The article summed up findings from two surveys investigating intimacy health in older Americans. Indiana University researchers reported earlier this year that 20% to 30% of long-lived Americans are active into their 80s. And a University of Chicago survey originally published in 2007 found that half of Americans continue to engage well into their 70s.

WHITEHOUSE STATION, N.J., and BEVERLY, Mass. (Dec. 2) Merck announced on Thursday it has inked a deal to acquire an insulin maker.

JERUSALEM — Oramed Pharmaceuticals, a developer of oral drug delivery solutions, has published an article in the Journal of Diabetes Science and Technology’s November issue describing evaluation of the company’s glucagon-like peptide (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.

BURLINGTON, Mass. — A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014, according to a new report by Decision Resources.

The Type 2 diabetes market in China totaled $1.4 billion in 2009, Decision Resources said.

NEW YORK — The entire retail store is a diabetes destination, and pharmacists are critical in educating and communicating with consumers to help them and their loved ones better manage the chronic disease. That was one of several important messages that industry leaders expressed during Drug Store News’ 8th Annual Diabetes Roundtable discussion on Tuesday in New York at the New York Athletic Club. More than 100 leading industry players gathered for the event, which also included the 12th Annual Industry Issues Summit in the afternoon.

DEERFIELD, Ill. — Walgreens' chief medical officer will discuss the evidence-based medicine design and impact of a diabetes management program delivered by pharmacists at both workplace and community pharmacies during an upcoming conference, the drug store chain said.

ST. LOUIS — The Journal of the American Dietetic Association has published a list of nutritional practice guidelines for people with Type 1 and Type 2 diabetes in its December issue.